- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Diagnostic Equipment
Snapshot for Cepheid Inc (CPHD)
| Open: | 38.1700 | Day's Range: | 37.7200 - 38.6100 | Volume: | 354,561 | Bid: | 38.4600 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 38.0900 | 52wk Range: | 29.7100 - 45.0000 | 1-Yr Rtn: | +20.11% | Ask: | 38.4700 |
Key Statistics for CPHD
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (12/2012) | 126.5461 |
| Earnings Per Share (USD) (ttm) | -0.0800 |
| Est. EPS (USD) (12/2012) | 0.3040 |
| Est. PEG Ratio | 5.8405 |
| Market Cap (M USD) | 2,524.01 |
| Shares Outstanding (M) | 65.61 |
| Enterprise Value (M USD) (ttm) | 2,420.02 |
| Enterprise Value/EBITDA (ttm) | 143.21 |
| Price/Book (mrq) | 10.9012 |
| Price/Sale (ttm) | 8.3218 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 07/20/2012 |
More CPHD Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for CPHD
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for CPHD
Cepheid, Inc. is a molecular diagnostics company dedicated to improving healthcare with its molecular systems and tests. The Company enables institutions to access the full power of molecular diagnostics with genetic testing for organisms and genetic-based diseases.
| Thomas L Gutshall "Tom"Chairman/Co-Founder | John L BishopChief Executive Officer |
| Andrew D MillerExec VP/CFO | Humberto ReyesExec VP/COO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page